Abstract
Cardiovascular disease (CVD) is the principal cause of mortality in patients with end-stage renal disease (ESRD). The aim of this study was to analyze carotid intima-media thickness (cIMT), endothelium-dependent dilatation (EDD), and left ventricular mass index (LVMI) as the cardiovascular risk markers and to investigate the independent risk factors of these markers in pediatric dialysis patients. This study included 39 children and adolescents undergoing dialysis (15 hemodialysis and 24 peritoneal dialysis) and 15 age- and gender-matched healthy subjects. The cIMT and EDD were assessed by high-resolution ultrasound, and LVMI was calculated from standard echocardiographic measurements. Compared with control subjects, cIMT standard deviation scores (SDS), LVMI, total homocysteine (tHcy), and high-sensitivity C-reactive protein (hs-CRP) values were significantly higher in patients, but EDD values did not differ. The mean hs-CRP level was significantly higher in hemodialysis (HD) patients than in peritoneal dialysis (PD) patients. The cIMT-SDS and LVMI were associated with several variables in univariate analysis. Stepwise linear regression analysis, indexed SBP (p = 0.017), and hemoglobin (p = 0.001) turned out to be independent variables for predicting LVMI, and a significant predictor of cIMT was indexed diastolic blood pressure (DBP) (p = 0.035). The causes of atherosclerosis and left ventricular hypertrophy are multifactorial in children and adolescents with ESRD. Better management of hypertension and anemia may be priorities for preventing or improving CVD in these patients.
Similar content being viewed by others
References
Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ (2002) Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 13:1918–1927
Goicoechea M, Garcia de Vinuesa S, Gomez-Campdera F, Luno J (2005) Predictive cardiovascular risk factors in patients with chronic kidney disease. Kidney Int 67(Suppl 93):S35–S38
Bayes B, Pastor MC, Bonal J, Romero R (2005) “New” cardiovascular risk factors in patients with chronic kidney disease: role of folic acid treatment. Kidney Int 67(Suppl 93):S39–S43
Bayes B, Pastor MC, Bonal J, Junca J, Hernandez JM, Riutort N, Foraster A, Romero R (2003) Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant 18:106–112
Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease - impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906–1914
Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105
Jourdan C, Wuhl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Troger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715
Ishizu T, Ishimitsu T, Yanagi H, Seo Y, Obara K, Moriyama N, Watanabe S, Yamaguchi I (2004) Effect of age on carotid arterial intima-media thickness in childhood. Heart Vessels 19:189–195
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. J Am Coll Cardiol 57:450–458
De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260
De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity of predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062
Groothoff JW, Lilien MR, van der Kar NCAJ, Wolff ED, Davin JC (2005) Cardiovascular disease as a late complication of end-stage renal disease in children. Pediatr Nephrol 20:374–379
Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494–1500
Haydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJA (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307–2312
Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 432:1478–1483
Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426–1433
Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN (2000) Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205–209
Oflaz H, Pusuroglu H, Genchallac H, Demirel S, Bugra Z, Sever MS, Yildiz A (2003) Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant 17:528–533
Lilien MR, Stroes ES, Op’t Roodt J, de Jongh S, Schroder CH, Koomans HA (2003) Vascular function in children after renal transplantation. Am J Kidney Dis 41:684–691
Lilien MR, Koomans HA, Schroder CH (2005) Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol 20:200–204
Lilien MR, Schroder CH, Koomans HA (2005) Endothelial function in pediatric patients on peritoneal dialysis: the need for data. Perit Dial Int 25(Suppl 3):S127–S129
Kari JA, Donald AE, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dorado B, Deanfield JE, Rees L (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468–472
Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH (2001) Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16:1189–1197
Blacher J, Demuth K, Guerin AP, Vadez C, Moatti N, Safar ME, London GM (1999) Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol 12:248–255
Buccianti G, Baragetti I, Bamonti F, Furiani S, Dorighet V, Patrosso C (2004) Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J Nephrol 17:405–410
Lilien M, Duran M, Van Hoeck K, Poll-The BT, Schroder C (1999) Hyperhomocyst(e)inaemia in children with chronic renal failure. Nephrol Dial Transplant 14:366–368
Sasaki T, Watanabe M, Nagai Y, Hoshi T, Takasawa M, Nukata M, Taguchi A, Kitagawa K, Kinoshita N, Matsumoto M (2002) Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction. Stroke 33:1493–1496
Taruangsri P, Ong-Ajyooth L, Ong-Ajyooth S, Chaiyasoot W, Leowattana W, Sritippayawan S, Vareesangthip K, Chanchairujira T, Vasuvattakul S, Shayakul C, Vanichakarn S (2005) Relationship between hyperhomocysteinemia and atherosclerosis in chronic hemodialysis patients. J Med Assoc Thai 88:1373–1381
Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife F (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902
Bennett-Richards K, Kattenhorn M, Donald A, Oakley G, Varghese Z, Rees L, Deanfield JE (2002) Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105:1810–1815
Righetti M, Serbelloni P, Milani S, Ferrario G (2006) Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Blood Purif 24:379–386
Poyrazoðlu HM, Düþünsel R, Narin F, Gunduz Z, Narin N, Karakukcu M, Tahan F (2004) Homocysteine and left ventricular hypertrophy in children with chronic renal failure. Pediatr Nephrol 19:193–198
Amore A, Coppo R (2002) Immunological basis of inflammation in dialysis. Nephrol Dial Transplant 17(Suppl 8):S16–S24
Oflaz H, Pusuroglu H, Genchallac H, Demirel S, Bugra Z, Sever MS, Yildiz A (2003) Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant 17:528–533
Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931–936
Haffner D, Hocher B, Mueller D, Simon K, Konig K, Richter CM, Eggert B, Schwarz J, Godes M, Nissel R, Querfeld U (2005) Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens 23:1067–1075
Mitsnefes MM, Kimball TR, Witt JA, Glascock BJ, Khoury PR, Daniels SR (2004) Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation 110:97–101
Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol 16:2796–2803
Mitsnefes MM, Schwartz SM, Daniels SR, Kimball TR, Khoury P, Strife CF (2001) Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant 5:279–284
Yildiz A, Oflaz H, Pusuroglu H, Mercanoglu F, Genchallac H, Akkaya V, Ikizler TA, Sever MS (2003) Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients. Am J Kidney Dis 41:616–623
Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S (2005) Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20:760–767
Acknowledgements
We would like to thank Dolli Yafet Aji, MD, for her excellent language and technical assistance. Financial support for this study was obtained from the Turkish Pediatric Association, and statistical analysis was supported by the Turkish Society of Nephrology Istanbul Branch.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Civilibal, M., Caliskan, S., Oflaz, H. et al. Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr Nephrol 22, 1021–1029 (2007). https://doi.org/10.1007/s00467-007-0451-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0451-0